MEHCQ (Chrome Holding Co) YoY EBITDA Growth: 53.55% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEHCQ Chrome Holding Co MEHCQ
58 GF Score
Price $3.50
View Full Analysis

What is Chrome Holding Co YoY EBITDA Growth?

Chrome Holding Co MEHCQ -2.78% 58 YoY EBITDA Growth is 53.55% as of Jun. 2025. GuruFocus rates MEHCQ with a GF Score™ of 58/100.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Chrome Holding Co's YoY EBITDA Growth for the quarter that ended in Jun. 2025 was 53.55%.

Chrome Holding Co's EBITDA per Share for the three months ended in Jun. 2025 was $-0.97.

Chrome Holding Co YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Chrome Holding Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chrome Holding Co YoY EBITDA Growth Chart

Chrome Holding Co Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial 13.40 -55.40 34.48 0.44 26.64

Chrome Holding Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.97 67.59 -11.48 53.55 100.00
MEHCQ
58GF Score
Chrome Holding Co MEHCQ
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chrome Holding Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Chrome Holding Co's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(-6.037--8.229)/ | -8.229 |
=26.64 %

Chrome Holding Co's YoY EBITDA Growth for the quarter that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (Q: Jun. 2025 )
=(EBITDA per Share (Q: Jun. 2025 )-EBITDA per Share (Q: Jun. 2024 )) / | EBITDA per Share (Q: Jun. 2024 )) |
=(-0.969--2.086)/ | -2.086 |
=53.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 53.55% mean?
Chrome Holding Co (MEHCQ) has a YoY EBITDA Growth of 53.55% as of Jun. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Chrome Holding Co and its competitors.
Is Chrome Holding Co's YoY EBITDA Growth too high?
Chrome Holding Co's current YoY EBITDA Growth is 53.55%. Overall, Chrome Holding Co has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Chrome Holding Co's YoY EBITDA Growth compare to BDSX and XGN?
Chrome Holding Co's YoY EBITDA Growth of 53.55% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Diagnostics & Research company?
A good YoY EBITDA Growth depends on the Medical Diagnostics & Research industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Chrome Holding Co and its competitors. Chrome Holding Co's current YoY EBITDA Growth is 53.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrome Holding Co stock overvalued right now?
Chrome Holding Co (MEHCQ) has a current YoY EBITDA Growth of 53.55%. The current YoY EBITDA Growth is 53.55%. Chrome Holding Co's overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Chrome Holding Co (MEHCQ), the current YoY EBITDA Growth is 53.55% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chrome Holding Co Business Description

Address 870 Market Street, Room 415, South San Francisco, CA, USA, 94102
Chrome Holding Co, formerly known as 23andMe Holding Co, is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes one main sector that is Consumer and Research Services. The company generates maximum revenue from the Consumer and Research Services segment.
58GF Score

Get the complete analysis for MEHCQ

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price